Table 2 |
|
|
Royal Marsden staging classification of testicular germ cell tumours |
|
|
Stage |
Criteria |
|
|
|
|
I |
no evidence of metastases |
|
|
|
|
IM |
no clinical evidence of metastases, but persistent elevation of serum tumour markers AFP and/or hCG |
|
|
|
|
II |
infradiaphragmatic lymph node metastases |
|
|
|
|
IIA |
metastases <2 cm in diameter |
|
|
|
|
IIB |
metastases 2-5 cm in diameter |
|
|
|
|
IIC |
metastases >5 cm in diameter |
|
|
|
|
III |
supradiaphragmatic lymph node metastases; status A, B, C as for stage II |
|
|
|
|
IV |
extra lymphatic metastases |
|
|
|
|
L1 |
≤3 lung metastases |
|
|
|
|
L2 |
>3 lung metastases, all ≤2 cm in diameter |
|
|
|
|
L3 |
>3 lung metastases, one or more >2 cm in diameter |
|
|
|
|
H+, Br+, Bo+ |
liver, brain, or bone metastases |
|
|
|
|
Holzik et al. Hereditary Cancer in Clinical Practice 2008 6:3 doi:10.1186/1897-4287-6-1-3 |
|
